Pablo Fernández‐Tussy

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Lucía Barbier‐Torres, Karen A. Fortner, Paula Iruzubieta et al. · Nature Communications · 2020 · 142 citations · Full text

Lipid Peroxidation, Pathology, Fatty Liver Disease +28

Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly

Jorge Simón, Maitane Núñez-García, Pablo Fernández‐Tussy et al. · Cell Metabolism · 2020 · 128 citations · Full text

Metabolic Syndrome, Hepatology, Biochemistry +12

The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

Lucía Barbier‐Torres, Paula Iruzubieta, David Fernández‐Ramos et al. · Nature Communications · 2017 · 107 citations · Full text

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer

Lucía Barbier‐Torres, Teresa C. Delgado, Juan L. García‐Rodríguez et al. · Oncotarget · 2014 · 89 citations · Full text

Deregulated neddylation in liver fibrosis

Imanol Zubiete‐Franco, Pablo Fernández‐Tussy, Lucía Barbier‐Torres et al. · Hepatology · 2016 · 80 citations · Full text